Alnylam Pharmaceuticals (ALNY) Stock News
$ALNY · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Alnylam Pharmaceuticals (ALNY) in the past 30 days. BORSA’s news read on ALNY is leaning bearish at 43/100, unchanged over 24 hours, based on 1 company event over the past 30 days. Alnylam Pharmaceuticals’ next earnings report is scheduled for Thursday, Oct 29.
The wire on $ALNY
newest first · updated · direct subject stories onlyRBC Capital lowered its price target for Alnylam Pharmaceuticals from $350.00 to $345.00.
bearish 35 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Alnylam Pharmaceuticals (ALNY) stock: common questions
What is the latest Alnylam Pharmaceuticals stock news?
The highest-impact ALNY story BORSA published in the past 30 days:
· RBC Capital cuts Alnylam Pharmaceuticals price target to $345.00Is the news on ALNY bullish or bearish?
BORSA’s news read on ALNY is leaning bearish at 43/100, unchanged over 24 hours, based on 1 company event over the past 30 days. It measures the news only: it is separate from price action and is not investment advice.